Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03207854 · ClinicalTrials.gov registry record
Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
A clinical trial of Hematopoietic and Lymphoid Cell Neoplasm and Malignant Neoplasm, sponsored by University of Southern California.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT03207854: Recruiting study of Hematopoietic and Lymphoid Cell Neoplasm and Malignant Neoplasm, sponsored by University of Southern California.
NCT03207854 is a study of Hematopoietic and Lymphoid Cell Neoplasm and Malignant Neoplasm that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 500 participants, below the 948-participant average among 104 other Hematopoietic and Lymphoid Cell Neoplasm trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03207854, a study of Hematopoietic and Lymphoid Cell Neoplasm and Malignant Neoplasm, is actively recruiting participants, sponsored by University of Southern California.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This research trial collects and stores blood, tissue, and bone marrow specimens from patients with cancer or blood disorders, and healthy volunteers to study the immune system in a variety of different types of experiments, as well as associated clinical data as appropriate, focused on understanding mechanisms of immunotherapy.
Primary Outcome
Tissue, blood, and bone marrow samples collected will be used to identify changes in immune system parameters in patients receiving immunotherapies (including immune checkpoint inhibitors, immunostimulatory/immunomodulatory agents, cellular therapies, stem cell transplantation) and compare to changes in patients receiving conventional chemotherapy, targeted-agent therapy, and healthy normal volunteers using multiparameter flow cytometry, time-of-flight mass cytometry, cytokine quantification, fu
Conditions Studied
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Laboratory Biomarker Analysis
- OTHER Questionnaire Administration
Study Locations (1)
California
- USC / Norris Comprehensive Cancer Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2017-04-12 |
| Est. Completion | 2027-04-12 |
What NCT03207854 shows while recruiting
NCT03207854 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 948-participant average among 104 other Hematopoietic and Lymphoid Cell Neoplasm trials with a reported enrollment target (47% lower).
The record links to 5 conditions, with Hematopoietic and Lymphoid Cell Neoplasm appearing as the primary indexed condition, and to 3 interventions - of which Biospecimen Collection is the first listed.
NCT03207854 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03207854 about?
NCT03207854 is a clinical study titled "Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers". This research trial collects and stores blood, tissue, and bone marrow specimens from patients with cancer or blood disorders, and healthy volunteers to study the immune system in a variety of different types of experiments, as well as associated clinical data as appropriate, focused on understandin...
What is the current status of trial NCT03207854?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2017-04-12. Estimated completion is 2027-04-12.
What conditions does trial NCT03207854 study?
This clinical trial studies the following conditions: Hematopoietic and Lymphoid Cell Neoplasm, Malignant Neoplasm, Healthy Subject, Hematologic and Lymphocytic Disorder, Immune System Disorder.
What interventions are being tested in trial NCT03207854?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Laboratory Biomarker Analysis (OTHER), Questionnaire Administration (OTHER).
Who is sponsoring clinical trial NCT03207854?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03207854 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hematopoietic and Lymphoid Cell Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03207854's enrollment target sits among peer trials
500 10th of 104 higher than 95 of 104 other Hematopoietic and Lymphoid Cell Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hematopoietic and Lymphoid Cell Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant
RECRUITING · NA
-
The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)
RECRUITING
-
Role of Gut Microbiome in Cancer Therapy
RECRUITING
-
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
RECRUITING · Phase 2
-
Increasing Knowledge and Interest in Cancer Clinical Trials
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI